79 related articles for article (PubMed ID: 26516695)
1. CKMT1 and NCOA1 expression as a predictor of clinical outcome in patients with advanced-stage head and neck squamous cell carcinoma.
Pavón MA; Parreño M; Téllez-Gabriel M; León X; Arroyo-Solera I; López M; Céspedes MV; Casanova I; Gallardo A; López-Pousa A; Mangues MA; Quer M; Barnadas A; Mangues R
Head Neck; 2016 Apr; 38 Suppl 1():E1392-403. PubMed ID: 26516695
[TBL] [Abstract][Full Text] [Related]
2. The expression of activin receptor-like kinase 1 among patients with head and neck cancer.
Chien CY; Chuang HC; Chen CH; Fang FM; Chen WC; Huang CC; Huang HY
Otolaryngol Head Neck Surg; 2013 Jun; 148(6):965-73. PubMed ID: 23447486
[TBL] [Abstract][Full Text] [Related]
3. Association between FAT1 mutation and overall survival in patients with human papillomavirus-negative head and neck squamous cell carcinoma.
Kim KT; Kim BS; Kim JH
Head Neck; 2016 Apr; 38 Suppl 1(Suppl 1):E2021-9. PubMed ID: 26876381
[TBL] [Abstract][Full Text] [Related]
4. Molecular profiling of head and neck squamous cell carcinoma.
Feldman R; Gatalica Z; Knezetic J; Reddy S; Nathan CA; Javadi N; Teknos T
Head Neck; 2016 Apr; 38 Suppl 1(Suppl 1):E1625-38. PubMed ID: 26614708
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of epigenetic inactivation of vascular endothelial growth factor receptors in head and neck squamous cell carcinoma.
Misawa Y; Misawa K; Kawasaki H; Imai A; Mochizuki D; Ishikawa R; Endo S; Mima M; Kanazawa T; Iwashita T; Mineta H
Tumour Biol; 2017 Jul; 39(7):1010428317711657. PubMed ID: 28718364
[TBL] [Abstract][Full Text] [Related]
6. The p16 (CDKN2a/INK4a) tumor-suppressor gene in head and neck squamous cell carcinoma: a promoter methylation and protein expression study in 100 cases.
Ai L; Stephenson KK; Ling W; Zuo C; Mukunyadzi P; Suen JY; Hanna E; Fan CY
Mod Pathol; 2003 Sep; 16(9):944-50. PubMed ID: 13679459
[TBL] [Abstract][Full Text] [Related]
7. The gene expression profile of inflammatory, hypoxic and metabolic genes predicts the metastatic spread of human head and neck squamous cell carcinoma.
Clatot F; Gouérant S; Mareschal S; Cornic M; Berghian A; Choussy O; El Ouakif F; François A; Bénard M; Ruminy P; Picquenot JM; Jardin F
Oral Oncol; 2014 Mar; 50(3):200-7. PubMed ID: 24387976
[TBL] [Abstract][Full Text] [Related]
8. Vasohibin-1 as a Novel Prognostic Factor for Head and Neck Squamous Cell Carcinoma.
Torii C; Hida Y; Shindoh M; Akiyama K; Ohga N; Maishi N; Ohiro Y; Ono M; Totsuka Y; Kitagawa Y; Tei K; Sato Y; Hida K
Anticancer Res; 2017 Mar; 37(3):1219-1225. PubMed ID: 28314285
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of micrometastatic cells detected by E48 (Ly-6D) reverse transcription-polymerase chain reaction in bone marrow of head and neck cancer patients.
Colnot DR; Nieuwenhuis EJ; Kuik DJ; Leemans CR; Dijkstra J; Snow GB; van Dongen GA; Brakenhoff RH
Clin Cancer Res; 2004 Dec; 10(23):7827-33. PubMed ID: 15585614
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of transcriptomics based hypoxia signatures in head- and neck squamous cell carcinoma.
Tawk B; Schwager C; Deffaa O; Dyckhoff G; Warta R; Linge A; Krause M; Weichert W; Baumann M; Herold-Mende C; Debus J; Abdollahi A
Radiother Oncol; 2016 Feb; 118(2):350-8. PubMed ID: 26711490
[TBL] [Abstract][Full Text] [Related]
11. Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas.
Rodrigo JP; García-Carracedo D; García LA; Menéndez S; Allonca E; González MV; Fresno MF; Suárez C; García-Pedrero JM
J Pathol; 2009 Mar; 217(4):516-23. PubMed ID: 18991334
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factor family aberrations as a putative driver of head and neck squamous cell carcinoma in an epidemiologically low-risk patient as defined by targeted sequencing.
Tillman BN; Yanik M; Birkeland AC; Liu CJ; Hovelson DH; Cani AK; Palanisamy N; Carskadon S; Carey TE; Bradford CR; Tomlins SA; McHugh JB; Spector ME; Brenner JCh
Head Neck; 2016 Apr; 38 Suppl 1(Suppl 1):E1646-52. PubMed ID: 26849095
[TBL] [Abstract][Full Text] [Related]
13. Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients.
Nathan CO; Amirghahri N; Rice C; Abreo FW; Shi R; Stucker FJ
Laryngoscope; 2002 Dec; 112(12):2129-40. PubMed ID: 12461330
[TBL] [Abstract][Full Text] [Related]
14. External validation of sTWEAK as a prognostic noninvasive biomarker for head and neck squamous cell carcinoma.
Terra X; Gómez D; García-Lorenzo J; Flores JC; Figuerola E; Mora J; Chacón MR; Quer M; Camacho M; León X; Avilés-Jurado FX
Head Neck; 2016 Apr; 38 Suppl 1():E1358-63. PubMed ID: 26676381
[TBL] [Abstract][Full Text] [Related]
15. Expression of haptoglobin predicts recurrence in head and neck squamous cell carcinoma.
Lee CC; Ho HC; Lee MS; Hung SK; Yu CC; Su YC
Clin Chim Acta; 2010 Aug; 411(15-16):1116-21. PubMed ID: 20417195
[TBL] [Abstract][Full Text] [Related]
16. EMS1 gene amplification correlates with poor prognosis in squamous cell carcinomas of the head and neck.
Rodrigo JP; García LA; Ramos S; Lazo PS; Suárez C
Clin Cancer Res; 2000 Aug; 6(8):3177-82. PubMed ID: 10955801
[TBL] [Abstract][Full Text] [Related]
17. The gene ratios c-MYC:cyclin-dependent kinase (CDK)N2A and CCND1:CDKN2A correlate with poor prognosis in squamous cell carcinoma of the head and neck.
Akervall J; Bockmühl U; Petersen I; Yang K; Carey TE; Kurnit DM
Clin Cancer Res; 2003 May; 9(5):1750-5. PubMed ID: 12738730
[TBL] [Abstract][Full Text] [Related]
18. Copy number gain of PIK3CA and MET is associated with poor prognosis in head and neck squamous cell carcinoma.
Brauswetter D; Dános K; Gurbi B; Félegyházi ÉF; Birtalan E; Meggyesházi N; Krenács T; Tamás L; Peták I
Virchows Arch; 2016 May; 468(5):579-87. PubMed ID: 26832731
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of the hypoxia markers CA IX and GLUT 1 and the cytokines VEGF and IL 6 in head and neck squamous cell carcinoma treated by radiotherapy +/- chemotherapy.
De Schutter H; Landuyt W; Verbeken E; Goethals L; Hermans R; Nuyts S
BMC Cancer; 2005 Apr; 5():42. PubMed ID: 15847702
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-kappaB signaling as characteristics of a high-risk head and neck squamous cell carcinoma.
Chung CH; Parker JS; Ely K; Carter J; Yi Y; Murphy BA; Ang KK; El-Naggar AK; Zanation AM; Cmelak AJ; Levy S; Slebos RJ; Yarbrough WG
Cancer Res; 2006 Aug; 66(16):8210-8. PubMed ID: 16912200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]